LIGAND PHARMACEUTICALS INCORPORATED Proceeds from Divestiture of Businesses
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2023-02-28
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from divestiture of businesses for fiscal 2022 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from divestiture of businesses for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from divestiture of businesses for fiscal 2020 was $22.06M.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from divestiture of businesses for fiscal 2019 was $0.00.
| Period end | Proceeds from Divestiture of Businesses 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2020-12-31 | $22.06M 10-K · filed 2023-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |